Postoperative topical mitomycin C in conjunctival squamous cell neoplasia

Esen K Akpek, Dilek Ertoy, Defne Kalayci, Hikmet Hasiripi

Research output: Contribution to journalArticle

Abstract

Purpose. To report the efficacy of topical mitomycin C in preventing local recurrences after incomplete surgical excision of conjunctival squamous cell neoplasia. Methods. Four patients presented with unilateral conjunctival tumors. Excisional biopsy results revealed conjunctival intraepithelial neoplasia with an intact basement membrane. Neoplastic cells were present in at least one of the surgical borders of the excised conjunctiva in all four cases. Patients were treated with topical mitomycin C 0.02% three times daily for 2 weeks to prevent recurrences. Results. All four patients were free of clinically detectable tumors after a mean follow-up period of 20 months (range, 16-23 months). Side effects included mild discomfort, redness, photophobia, and punctate epithelial keratopathy that subsided on discontinuation of the medication. Conclusion. Postoperative topical mitomycin C application may be a useful adjunct to prevent recurrences in patients with incompletely excised conjunctival squamous cell neoplasia.

Original languageEnglish (US)
Pages (from-to)59-62
Number of pages4
JournalCornea
Volume18
Issue number1
StatePublished - 1999

Fingerprint

Mitomycin
Epithelial Cells
Neoplasms
Recurrence
Photophobia
Conjunctiva
Basement Membrane
Biopsy

Keywords

  • Conjunctiva
  • Mitomycin C
  • Squamous cell neoplasia

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Akpek, E. K., Ertoy, D., Kalayci, D., & Hasiripi, H. (1999). Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea, 18(1), 59-62.

Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. / Akpek, Esen K; Ertoy, Dilek; Kalayci, Defne; Hasiripi, Hikmet.

In: Cornea, Vol. 18, No. 1, 1999, p. 59-62.

Research output: Contribution to journalArticle

Akpek, EK, Ertoy, D, Kalayci, D & Hasiripi, H 1999, 'Postoperative topical mitomycin C in conjunctival squamous cell neoplasia', Cornea, vol. 18, no. 1, pp. 59-62.
Akpek, Esen K ; Ertoy, Dilek ; Kalayci, Defne ; Hasiripi, Hikmet. / Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. In: Cornea. 1999 ; Vol. 18, No. 1. pp. 59-62.
@article{cf9f339d75d94673b9539dcbff4317e5,
title = "Postoperative topical mitomycin C in conjunctival squamous cell neoplasia",
abstract = "Purpose. To report the efficacy of topical mitomycin C in preventing local recurrences after incomplete surgical excision of conjunctival squamous cell neoplasia. Methods. Four patients presented with unilateral conjunctival tumors. Excisional biopsy results revealed conjunctival intraepithelial neoplasia with an intact basement membrane. Neoplastic cells were present in at least one of the surgical borders of the excised conjunctiva in all four cases. Patients were treated with topical mitomycin C 0.02{\%} three times daily for 2 weeks to prevent recurrences. Results. All four patients were free of clinically detectable tumors after a mean follow-up period of 20 months (range, 16-23 months). Side effects included mild discomfort, redness, photophobia, and punctate epithelial keratopathy that subsided on discontinuation of the medication. Conclusion. Postoperative topical mitomycin C application may be a useful adjunct to prevent recurrences in patients with incompletely excised conjunctival squamous cell neoplasia.",
keywords = "Conjunctiva, Mitomycin C, Squamous cell neoplasia",
author = "Akpek, {Esen K} and Dilek Ertoy and Defne Kalayci and Hikmet Hasiripi",
year = "1999",
language = "English (US)",
volume = "18",
pages = "59--62",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Postoperative topical mitomycin C in conjunctival squamous cell neoplasia

AU - Akpek, Esen K

AU - Ertoy, Dilek

AU - Kalayci, Defne

AU - Hasiripi, Hikmet

PY - 1999

Y1 - 1999

N2 - Purpose. To report the efficacy of topical mitomycin C in preventing local recurrences after incomplete surgical excision of conjunctival squamous cell neoplasia. Methods. Four patients presented with unilateral conjunctival tumors. Excisional biopsy results revealed conjunctival intraepithelial neoplasia with an intact basement membrane. Neoplastic cells were present in at least one of the surgical borders of the excised conjunctiva in all four cases. Patients were treated with topical mitomycin C 0.02% three times daily for 2 weeks to prevent recurrences. Results. All four patients were free of clinically detectable tumors after a mean follow-up period of 20 months (range, 16-23 months). Side effects included mild discomfort, redness, photophobia, and punctate epithelial keratopathy that subsided on discontinuation of the medication. Conclusion. Postoperative topical mitomycin C application may be a useful adjunct to prevent recurrences in patients with incompletely excised conjunctival squamous cell neoplasia.

AB - Purpose. To report the efficacy of topical mitomycin C in preventing local recurrences after incomplete surgical excision of conjunctival squamous cell neoplasia. Methods. Four patients presented with unilateral conjunctival tumors. Excisional biopsy results revealed conjunctival intraepithelial neoplasia with an intact basement membrane. Neoplastic cells were present in at least one of the surgical borders of the excised conjunctiva in all four cases. Patients were treated with topical mitomycin C 0.02% three times daily for 2 weeks to prevent recurrences. Results. All four patients were free of clinically detectable tumors after a mean follow-up period of 20 months (range, 16-23 months). Side effects included mild discomfort, redness, photophobia, and punctate epithelial keratopathy that subsided on discontinuation of the medication. Conclusion. Postoperative topical mitomycin C application may be a useful adjunct to prevent recurrences in patients with incompletely excised conjunctival squamous cell neoplasia.

KW - Conjunctiva

KW - Mitomycin C

KW - Squamous cell neoplasia

UR - http://www.scopus.com/inward/record.url?scp=0032924427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032924427&partnerID=8YFLogxK

M3 - Article

C2 - 9894938

AN - SCOPUS:0032924427

VL - 18

SP - 59

EP - 62

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 1

ER -